- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Elo Mutual Pension Insurance Co Increases Bristol Myers Squibb Position
Firm boosts stake in biopharmaceutical company by 23.6% in Q3
Published on Mar. 2, 2026
Got story updates? Submit your updates here. ›
Elo Mutual Pension Insurance Co increased its holdings in shares of Bristol Myers Squibb Company (NYSE:BMY) by 23.6% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm now owns 302,104 shares of the biopharmaceutical company's stock, valued at $13.63 million.
Why it matters
This investment move by Elo Mutual Pension Insurance Co reflects growing institutional confidence in Bristol Myers Squibb's long-term prospects as a leading biopharmaceutical firm focused on cancer, immunology, and other key therapeutic areas.
The details
Elo Mutual Pension Insurance Co acquired an additional 57,692 shares of Bristol Myers Squibb during the third quarter, bringing its total position to 302,104 shares. The firm's holdings in BMY are now valued at $13.63 million, up from $11 million at the end of the prior quarter.
- Elo Mutual Pension Insurance Co increased its Bristol Myers Squibb holdings during the 3rd quarter of 2026.
The players
Elo Mutual Pension Insurance Co
A Finnish pension insurance company that manages retirement funds.
Bristol Myers Squibb Company
A global biopharmaceutical company headquartered in Princeton, New Jersey, focused on discovering, developing and delivering medicines for serious diseases.
The takeaway
Elo Mutual Pension Insurance Co's increased investment in Bristol Myers Squibb reflects growing institutional confidence in the biopharmaceutical firm's long-term growth potential as it advances its pipeline of cancer, immunology, and other therapies.
